Post
Weekly insulin analogues approaching approval could herald change
Upcoming weekly insulin candidates can reduce the injection burden on patients with diabetes and ease the load on healthcare resources, …
“Lack of harmonisation in Europe” hindering gene therapy growth
Amid a US regulatory landscape promoting collaboration in cell and gene therapy development, SpliceBio’s CEO Miquel Vila-Perelló has questioned why …
Chemomab touts study confirming CCL24 link to systemic sclerosis severity
Clinical-stage biotech Chemomab Therapeutics has announced the publication of a study highlighting that high serum CCL24 levels are linked to …
OncoX inks licensing deal worth over $26m for NSCLC therapy
US-based ABVC BioPharma has sold the rights to its botanical drug extract therapy, BLEX 404, for the treatment of non-small …
Inflammation among current dementia research focus, says Alchemab CSO
Inflammation, cell metabolism and neuronal health are current key areas of focus for dementia researchers, according to Jane Osbourn, chief …
Comprehensive clinical trial services
Comprehensive clinical trial services: Introduction In the intricate and highly regulated world of clinical research, selecting the right clinical trial services …
Denali Therapeutics gets grant for polypeptides targeting transferrin receptor for brain delivery
Denali Therapeutics has patented a method to generate polypeptides that target transferrin receptor-expressing cells, including those across the blood-brain barrier. …
Cue Biopharma gets grant for fusion polypeptide with variant IL-2 and antibody fc region
Cue Biopharma has been granted a patent for variant immunomodulatory polypeptides and fusion polypeptides, including T-cell modulatory multimeric polypeptides. The …
Tenaya Therapeutics gets grant for compound for treating diseases by inhibiting HDAC6 activity
Tenaya Therapeutics has been granted a patent for compounds that inhibit HDAC6 activity, potentially treating various diseases. The formula for …
RAPT Therapeutics gets grant for inhibiting hematopoietic progenitor kinase 1 using pyrazole pyrimidine compounds
RAPT Therapeutics has been granted a patent for pyrazole pyrimidine compounds that target hematopoietic progenitor kinase 1. The compounds can …
Ikena Oncology gets grant for cancer treatment method using compounds of formula i
Ikena Oncology has been granted a patent for compounds and methods for treating cancer. The invention includes specific compounds and …
Vir Biotechnology gets grant for multispecific antibodies for zika virus infection treatment
Vir Biotechnology has been granted a patent for multispecific antibodies that target distinct Zika virus epitopes, effectively neutralizing ZIKV infection. …
Foghorn Therapeutics gets grant for compounds for treating BAF complex-related disorders
Foghorn Therapeutics has been granted a patent for compounds designed to treat BAF complex-related disorders. The compounds have a specific …
Huadong Medicine gets grant for multi-domain active protein for treating metabolic diseases
Huadong Medicine has been granted a patent for a multi-domain active protein designed to treat metabolic diseases. The protein has …
Sword Health gets grant for method for synchronizing timestamps from embedded wireless data sensors
Sword Health has patented a method for synchronizing data packets from embedded wireless sensors to monitor patient body motion. The …